| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600840306 |
| P698 | PubMed publication ID | 7616366 |
| P2093 | author name string | T Järvinen | |
| V J Stella | |||
| K Järvinen | |||
| N Schwarting | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioavailability | Q461809 |
| P304 | page(s) | 295-299 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogs | |
| P478 | volume | 84 |
| Q44217542 | 6-O-alpha-(4-O-alpha-D-glucuronyl)-D-glucosyl-beta-cyclodextrin: solubilizing ability and some cellular effects |
| Q44225174 | A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. |
| Q58866642 | A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N‐phosphonooxymethyl prodrugs in rats and dogs |
| Q58199045 | Bioavailability of Cinnarizine in Dogs: Effect of SNEDDS Loading Level and Correlation with Cinnarizine Solubilization During In Vitro Lipolysis |
| Q77619770 | Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms |
| Q46982912 | Complexation of tauro- and glyco-conjugated bile salts with three neutral beta-CDs studied by ACE. |
| Q30586337 | Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin |
| Q57374231 | Cyclodextrins in drug delivery systems |
| Q40895926 | Cyclodextrins: their future in drug formulation and delivery |
| Q77484295 | Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD |
| Q45179801 | Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs |
| Q44806110 | Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations |
| Q73120411 | Drug-excipient interactions and their affect on absorption |
| Q73088470 | Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroids |
| Q33794561 | Factors influencing the bioavailability of peroral formulations of drugs for dogs |
| Q73367828 | Fractionation and characterization of 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin) |
| Q31875999 | Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether beta-cyclodextrins (SBE) and danazol-SBE inclusion complexes |
| Q38011598 | Impact of excipient interactions on drug bioavailability from solid dosage forms |
| Q74828913 | Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD |
| Q34190317 | Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract |
| Q73367833 | Isolation and characterization by NMR spectroscopy of three monosubstituted 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin) |
| Q33855343 | Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. |
| Q89910005 | Multicomponent cyclodextrin system for improvement of solubility and dissolution rate of poorly water soluble drug |
| Q42854119 | Oral bioavailability of a poorly aqueous drug from three different SBE7-β-cyclodextrin based formulations in beagle dogs |
| Q41219657 | Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery |
| Q43703430 | Quantitation of entacapone glucuronide in rat plasma by on-line coupled restricted access media column and liquid chromatography-tandem mass spectrometry |
| Q38283583 | Recent advances in delivery systems and therapeutics of cinnarizine: a poorly water soluble drug with absorption window in stomach. |
| Q41777003 | SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization |
| Q90341008 | Stabilization benefits of single and multi-layer self-nanoemulsifying pellets: A poorly-water soluble model drug with hydrolytic susceptibility |
| Q71809723 | The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins |
Search more.